Hantz Financial Services’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AI
Hantz Financial Services's HAE Position: Q2 2026 in Review
Hantz Financial Services increased its Haemonetics (HAE) stake by 59% in Q2 2026, buying an estimated $44.5K and bringing the position to 1,863 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #1261.
Hantz Financial Services first reported a position in HAE in Q3 2020 and has held it in 24 quarters since. The position peaked at $194K in Q3 2020. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Hantz Financial Services held 1,863 shares of Haemonetics worth $140K as of Q2 2026.
- Hantz Financial Services bought 692 Haemonetics shares in Q2 2026, an estimated $44.5K.
- Haemonetics made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1261 holding.
- Hantz Financial Services first reported a position in Haemonetics in Q3 2020 and has held it in 24 quarters since.
- Hantz Financial Services's Haemonetics position peaked at $194K in Q3 2020.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.